Dr. Himanshu D. Desai, MD

Dr. Desai practices at Sentara Albemarle Cancer Care Center - HOPD in Elizabeth City, North Carolina.

Dr. Desai's NPI, 1013153014, was assigned on December 21, 2008. Dr. Desai graduated from N.H.L Municipal Medical College in 2000. Dr. Desai holds Virginia license 0101246880.

Dr. Desai's primary practice is Sentara Albemarle Cancer Care Center - HOPD, at 1144 N Road St, Elizabeth City, NC 27909.

Dr. Desai's primary practice is Sentara Albemarle Cancer Care Center - HOPD in Elizabeth City, North Carolina. Dr. Desai is also affiliated with Sentara Albemarle Medical Center. The medical group on file is Chesapeake Regional Medical Group. Dmand AI also links Dr. Desai to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desai practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Desai's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Desai is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Desai's licenses on file in 3 states: Virginia, North Carolina and Indiana.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, pleural effusion, pneumonia and pulmonary fibrosis among the conditions Dr. Desai treats.

CMS data shows 2,326 Medicare services from Dr. Desai across 17 procedure codes in 2024, for 761 Medicare patients. Medicare paid $107,838 for them.

CMS counts 761 Medicare patients who saw Dr. Desai in 2024. The largest group is 65 to 74, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Desai's median patient age at 71, with 59% women.

In 2024, Dr. Desai wrote 5,176 Medicare Part D claims for 841 patients. 56% of them were for generic drugs. CMS names the drug for 5,014 of them, across 40 drugs with 11 or more claims each, at $1,950,740 in total drug cost. In 2023, CMS named 5,089 claims across 40 drugs.

Dr. Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Desai as offering telehealth.

Dmand AI links 16 papers to Dr. Desai, published from 2008 to 2017. 2012 was the busiest year, with 3. The most frequent topics are Intensive Care Units, Hemodynamics and Patient Admission. Dr. Desai has published most often in J Intensive Care Med. Dr. Desai's most frequent co-authors are Sanjay Sethi, MD, Ali Albert El Solh and David Paul Evans, MD.

CMS Open Payments shows 843 general payments to Dr. Desai from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. GlaxoSmithKline, LLC. paid the most, $95,954.

Dr. Desai graduated from N.H.L Municipal Medical College in 2000.

Dr. Desai is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.